by BSPGHAN | Dec 20, 2021 | News
Dear members
I would like to personally thank the PGHAN Audit Steering Group, co chaired by John Fell and Ed Gaynor, Calvin Down from the RCPCH and all colleagues across the UK who have put time and effort into collecting and submitting information for the audit. This work continued to completion during the incredibly challenging circumstances of the COVID-19 pandemic.
This report, published jointly by The British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) and the RCPCH, highlights the main findings and recommendations identified through an audit of the provision of paediatric gastroenterology, hepatology and nutrition services for infants, children and young people with a wide range of conditions across the UK. Its recommendations offer healthcare professionals and providers expert guidance to drive improvement where needed.
The News page is here :https://www.rcpch.ac.uk/news-events/news/paediatricians-launch-landmark-report-gastrointestinal-liver-nutritional-disorders
Download your copy of The PGHAN/Audit report
Download Summaryof the PGHAN/ Audit report
Also see tweets https://twitter.com/RCPCHtweets/status/1471489611054551041
Sue Protheroe
BSPGHAN President 2019 – 2022
by BSPGHAN | Aug 22, 2021 | News
Dear members
Please see updated Guidance from the JCVI
https://www.gov.uk/government/publications/jcvi-statement-august-2021-covid-19-vaccination-of-children-and-young-people-aged-12-to-17-years
in addition to previous advice
https://www.gov.uk/government/publications/covid-19-vaccination-of-children-and-young-people-aged-12-to-17-years-jcvi-statement
At this time,
- the Pfizer-BioNTech BNT162b2 vaccine is the only vaccine authorised for persons aged 12 to 17 years in the UK
- JCVI advises that all 16 to 17-year-olds should be offered a first dose of Pfizer-BNT162b2 vaccine.
- Persons aged 12 to 15 years with specific underlying health conditions that put them at risk of severe COVID-19, should be offered 2 doses of Pfizer-BNT162b2 vaccine with an interval of 8 weeks between doses.
This currently includes children with severe neuro-disabilities, Down’s Syndrome, underlying conditions resulting in immunosuppression, profound and multiple learning disabilities (PMLD), severe learning disabilities or who are on the learning disability register. Details regarding additional person-groups with underlying health conditions to be offered vaccination will be provided as updates in the Green Book.
Children and young people aged 12 years and over who are household contacts of persons (adults or children) who are immunosuppressed should be offered 2 doses of Pfizer-BNT162b2 vaccine.
The rollout of Covid vaccination in England will be led through primary care. The letter notes: “We recognise that not all eligible 12-15 year olds may be identified through the GP record. Therefore, any approach by parents of children at increased risk should be considered and clinical judgement used around eligibility in line with JCVI advice. In addition, trusts may refer 12-15 year olds for a COVID-19 vaccination if they consider them to be eligible”
Letter to primary care –
https://www.england.nhs.uk/coronavirus/publication/covid-19-vaccination-programme-actions-for-all-practices-to-support-vaccinating-eligible-12-15-year-olds/
FAQs on Vaccination delivery operations
https://www.england.nhs.uk/coronavirus/publication/vaccinating-children-and-young-people-faq
Best wishes
Sue
Dr S Protheroe
BSPGHAN President
by BSPGHAN | Jul 1, 2021 | BSPGHAN Education Series, BSPGHAN Education Series- Gastroenterology, Education
This page is restricted to BSPGHAN members.
Please login.
by BSPGHAN | Jun 4, 2021 | News
The College has recently updated its webpage on the COVID-19 vaccine programme with some FAQs. This is available alongside advice for paediatricians published earlier this year on the eligibility of children and young people for COVID-19 vaccines in phase 1 of the programme. We're continuing to monitor these issues and will update the FAQ page as the situation develops.
With best wishes,
Kate
Kate Webb
Health Policy Lead
Royal College of Paediatrics and Child Health
